Serum protein profiling of B-cell lymphoma cohorts using the IMMRay microarray technology
In the clinic today, patients with relapsed or aggressive lymphoma are often not sampled as no reliable test for risk are available and invasive biopsies are considered to provide no or limited information of clinical use. The only way of getting biological information on the disease for these patients, is by non-invasive method, such as blood sampling. Methods that detect disease specific charact
